Select Medical Corporati... (SEM)
NYSE: SEM
· Real-Time Price · USD
15.24
0.32 (2.14%)
At close: May 12, 2025, 3:59 PM
14.96
-1.84%
After-hours: May 12, 2025, 05:30 PM EDT
Select Medical Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Service, Other Revenue | 511.57M | 6.17B | 5.87B | 5.78B | 5.11B | 5.04B |
| Service, Other Revenue Growth | -91.71% | +5.14% | +1.52% | +13.22% | +1.32% | n/a |
| Health Care, Patient Service Revenue | 4.68B | 1.49B | 1.45B | 1.42B | 1.38B | 1.41B |
| Health Care, Patient Service Revenue Growth | +214.62% | +2.59% | +2.08% | +2.46% | -2.06% | n/a |
| Health Care, Patient Service, Medicare Revenue | 1.49B | 4.69B | 4.42B | 4.36B | 3.72B | 3.63B |
| Health Care, Patient Service, Medicare Revenue Growth | -68.17% | +5.98% | +1.33% | +17.23% | +2.65% | n/a |
| Health Care, Patient Service, Non-Medicare Revenue | 3.18B | 491.64M | 462.98M | 421.71M | 424.23M | 413.21M |
| Health Care, Patient Service, Non-Medicare Revenue Growth | +547.57% | +6.19% | +9.78% | -0.59% | +2.67% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 33.01M | 80.2M | 47.35M | 49.7M | 48.45M | 44.09M | 41.32M | 42.51M | 42.28M | 38.76M | 39.49M | 37.27M | 37.51M | 37.95M | 37.88M | 35.74M | 35.4M | 35.23M | 35.52M | 33.46M | 33.83M | 34.06M | 34.38M | 31.34M | 28.68M | 30.32M | 29.98M | 29.19M | 31.78M | 30.63M | 27.07M | 28.27M | 28.07M | 25.7M | 27.09M | 25.87M | 28.27M | 24.14M | 22.2M | 24.04M | 21.68M |
| Selling, General, and Administrative Revenue Growth | -58.84% | +69.38% | -4.74% | +2.59% | +9.88% | +6.71% | -2.80% | +0.54% | +9.07% | -1.84% | +5.96% | -0.65% | -1.15% | +0.17% | +6.01% | +0.94% | +0.49% | -0.81% | +6.14% | -1.09% | -0.68% | -0.94% | +9.72% | +9.28% | -5.41% | +1.14% | +2.68% | -8.14% | +3.75% | +13.18% | -4.28% | +0.71% | +9.24% | -5.12% | +4.71% | -8.48% | +17.12% | +8.71% | -7.65% | +10.92% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |